Role of IL-1α in cisplatin-induced acute renal failure in mice

Jay-Wook Lee1, Woo-Jin Nam, Min-Jee Han

  • 1Department of Internal Medicine, Chung-Ang University College of Medicine, Seoul, Korea.

Abstract

Insights

Mice lacking interleukin-1 alpha (IL-1α) show protection against cisplatin-induced acute renal failure (ARF). This suggests IL-1α deficiency may explain the protective effects seen in caspase-1 knockout mice.

Area of Science:

  • Nephrology
  • Immunology
  • Toxicology

Background:

  • Caspase-1 knockout mice are protected from cisplatin-induced acute renal failure (ARF).
  • These mice are also deficient in interleukin-1 alpha (IL-1α).

Purpose of the Study:

  • To investigate if IL-1α deficiency is the mechanism behind protection against cisplatin-induced ARF in caspase-1 knockout mice.

Main Methods:

  • Cisplatin was administered to wild-type C57BL/6 mice to induce ARF.
  • Renal IL-1α levels were measured.
  • IL-1α knockout mice were assessed for protection against cisplatin-induced ARF.
  • Immune cell infiltration (macrophages, NK, and NKT cells) was analyzed.

Main Results:

  • Renal IL-1α levels increased in wild-type mice post-cisplatin treatment.
  • IL-1α knockout mice demonstrated protection against cisplatin-induced ARF.
  • No significant differences in neutrophil or specific immune cell infiltration were observed between groups.

Conclusions:

  • Mice lacking IL-1α are protected from cisplatin-induced ARF.
  • IL-1α deficiency likely contributes to the protection observed in caspase-1 knockout mice.
  • Further research into the protective mechanisms in IL-1α knockout mice is warranted.

Related Concept Videos